Skip to content

Advertisement

  • Research article
  • Open Access

A preliminary study of osteochondral regeneration using a scaffold-free three-dimensional construct of porcine adipose tissue-derived mesenchymal stem cells

  • 1,
  • 2,
  • 3,
  • 4,
  • 4,
  • 1,
  • 5 and
  • 1Email author
Journal of Orthopaedic Surgery and Research201510:35

https://doi.org/10.1186/s13018-015-0173-0

©  Murata et al.; licensee BioMed Central. 2015

  • Received: 25 August 2014
  • Accepted: 25 February 2015
  • Published:

Abstract

Background

Osteoarthritis (OA) is a major joint disease in humans and many other animals. Consequently, medical countermeasures for OA have been investigated diligently. This study was designed to examine the regeneration of articular cartilage and subchondral bone using three-dimensional (3D) constructs of adipose tissue-derived mesenchymal stem cells (AT-MSCs).

Methods

AT-MSCs were isolated and expanded until required for genetical and immunological analysis and construct creation. A construct consisting of about 760 spheroids that each contained 5.0 × 104 autologous AT-MSCs was implanted into an osteochondral defect (diameter: 4 mm; depth: 6 mm) created in the femoral trochlear groove of two adult microminipigs. After implantation, the defects were monitored by computed tomography every month for 6 months in animal no. 1 and 12 months in animal no. 2.

Results

AT-MSCs were confirmed to express the premature genes and to be positive for CD90 and CD105 and negative for CD34 and CD45. Under specific nutrient conditions, the AT-MSCs differentiated into osteogenic, chondrogenic, and adipogenic lineages, as evidenced by the expressions of related marker genes and the production of appropriate matrix molecules. A radiopaque area emerged from the boundary between the bone and the implant and increased more steadily upward and inward for the implants in both animal no. 1 and animal no. 2. The histopathology of the implants after 6 months revealed active endochondral ossification underneath the plump fibrocartilage in animal no. 1. The histopathology after 12 months in animal no. 2 showed not only that the diminishing fibrocartilage was as thick as the surrounding normal cartilage but also that massive subchondral bone was present.

Conclusions

The present results suggest that implantation of a scaffold-free 3D construct of AT-MSCs into an osteochondral defect may induce regeneration of the original structure of the cartilage and subchondral bone over the course of 1 year, although more experimental cases are needed.

Keywords

  • Regeneration
  • Cartilage
  • Bone
  • Scaffold-free
  • Three-dimensional construct
  • Stem cell
  • Adipose tissue
  • Computed tomography
  • Histopathology
  • Porcine

Background

Osteoarthritis (OA) is a major joint disease contributing to midlife and geriatric locomotor dysfunction, and the associated disability can decrease quality of life in humans [1]. OA slowly progresses not only as a result of traumatic injuries to joint structures [2] but also through many exacerbating factors such as age, sex, body mass index, occupation, bone shape, and genetic factors regulating proteolytic enzymes [3-5]. In advanced OA, cartilage degeneration and subchondral bone sclerosis may be worsened by the usual mechanical load of daily activities [6], and therefore surgical strategies to reconstruct both the bone and cartilage have been investigated to restore joint structure and function [7]. A particular issue of interest in recent studies has been the complete regeneration of hyaline cartilage covering the subchondral bone.

Although a clinical study of osteochondral autografts from non-load-bearing sites implanted into deteriorated sites showed favorable outcomes following surgery (clinical improvement in 79%–94% of OA patients) [8], a loss of clinically sound cartilage at the donor sites is associated with autologous osteochondral transfer [9]. Studies on surgical procedures using a combination of artificial bone and autologous chondrocytes seeded into a collagen scaffold have also shown favorable restoration of cartilage [10,11]. However, some studies have suggested associated problems such as isolation of few chondrocytes from a small piece of normal cartilage [10] and dedifferentiation of chondrocytes during passages in culture [12]. To solve these problems, stem cells have recently received attention in a study [13].

Stem cells are defined as immature cells that have the ability for self-renewal and the potential for multilineage differentiation into specific cells. Mesenchymal stem cells (MSCs) derived from bone marrow (BM) and adipose tissue (AT) have mostly been used to demonstrate differentiation into bone and cartilage in vitro [14,15]. BM-derived MSCs (BM-MSCs) appear to have some disadvantages including decreased numbers and deterioration of the cells depending on senescence and natural transformation caused by genomic instability [16]. Previous experiments have shown age-related decreases in the yield rate, growth rate, and differentiation potential of BM-MSCs in rats and humans [17,18]. On the other hand, the advantages of AT-derived MSCs (AT-MSCs) are that abundant cells can be isolated from AT and their cellular proliferation rate may be higher in mature animals [19]. Furthermore, given that obesity is undesirable in OA patients, the regenerative strategy for bone and cartilage using unwanted AT could be reasonable and acceptable by many OA patients. It has been reported that AT-MSCs hardly differentiate into chondrocytes [20]. However, a recent study using rabbits demonstrated the regeneration of bone and cartilage after implantation of scaffold-free three-dimensional (3D) constructs of AT-MSCs into osteochondral defects [21]. This report also contains a novel strategy for scaffold-free cell implantation.

Previous studies indicated that scaffolds composed of materials such as collagen and hyaluronic acid could be useful for promoting cell adhesion, proliferation, and chondrogenic differentiation [22,23], and bone regeneration using AT-MSCs seeded into hydroxyapatite has also been investigated [24]. However, artificial materials may induce xenobiotic reactions through immune reactions in the tissue [25].

In many previous studies, bone and cartilage regeneration through various cell therapies has been evaluated in the knee joint of rabbits [26-30]. However, to obtain meaningful results that are appropriate for extrapolating bone and cartilage regeneration to human OA, we expect that pigs will provide a more appropriate animal model than rabbits. Microminipigs (MMPigs) have similar behavior patterns to human daily life, as they spend time standing and walking in the daytime and sleeping at night [31,32]. In contrast, rabbits usually sit in cages. This study was designed to evaluate the regeneration of articular cartilage and subchondral bone using 3D constructs of autologous AT-MSCs in MMPigs.

Materials and methods

Animals

Two MMPigs (Fuji Micra, Shizuoka, Japan), designated animal no. 1 (male) and animal no. 2 (female), were used in this study. Their body weights and ages were 13.8 kg and 25 months, and 14.6 kg and 23 months, respectively. All procedures in this study were approved by the Animal Care and Use Committee of Kagoshima University (Approval No. A11037). Ten to fifteen grams of cervical AT per animal was aseptically obtained under general anesthesia.

Isolation and expansion of AT-MSCs

The AT samples were minced and digested for 90 min in phosphate-buffered saline (PBS) containing 0.1% collagenase (Collagenase Type I; Worthington Biochemical, Lakewood, NJ). The digested cell suspensions were filtered through a 70-μm-pore-diameter membrane (Cell Strainer; BD, Franklin Lakes, NJ) and centrifuged at 160 × g for 5 min at room temperature. After decanting the supernatant, the pellet was resuspended with PBS and centrifuged. The supernatant was removed, and the pellet was resuspended and plated on a 150-cm2 culture dish (Tissue Culture Dish φ 150; TPP, Trasadingen, Switzerland) in complete culture medium (CCM): Dulbecco’s modified Eagle’s medium (DMEM; Life Technologies, Carlsbad, CA) containing 10% fetal bovine serum (FBS; Thermo Fisher Scientific, Waltham, MA) and 1% antibiotic-antifungal preparation (100 U/ml penicillin G, 100 μg/ml streptomycin, 0.25 μg/ml amphotericin B; Antibiotic-Antimycotic; Life Technologies). Following incubation at 37 °C under 5% CO2 for 7 days, the cells adhering to the bottom of the dish were washed with PBS and cultured in CCM. The medium was changed on day 7 at passage 0. At day 10, the cells were harvested with 0.25% trypsin and 1 mM EDTA (Trypsin-EDTA; Life Technologies) diluted by adding five volumes of PBS and centrifuged. After decanting the supernatant, the pellet was rinsed with CCM, and the cells were replated at 5 × 105 cells per 150-cm2 dish and cultured for 6 days. The medium was changed every 3 days for 6 days during passage 1. This serial process of passaging was repeated until the cells were required for analysis and construct creation. The cells were used for creating the constructs at passage 4. Immunological surface markers and multipotency of the cells were analyzed at passage 5.

Genetic and molecular specificity of AT-MSCs

Ten thousand cells were used to analyze the specific gene expressions in MSCs. Total RNA from the cells was prepared with an RNA isolation kit (MirVana miRNA Isolation Kit; Life Technologies), according to the manufacturer’s instructions. The isolated RNA was converted to cDNA and amplified with a TAKARA RT-PCR system (PCR Thermal Cycler MP; Takara Bio, Otsu, Japan) and RT-PCR kit (ReverTra Dash; Toyobo, Osaka, Japan). Specific PCR primers were used to amplify octamer-binding transcription factor 4 (OCT-4), sex-determining region Y box 2 (SOX-2), Krüppel-like factor 4 (KLF-4), cellular myelocytomatosis oncogene (C-MYC), and homeobox protein NANOG (NANOG) as premature marker genes. The conditions and expected sizes of the products are summarized in Table 1. Ten thousand cells were resuspended in 500 μl of staining buffer (SB; PBS containing 1% FBS) and incubated for 30 min at 4 °C with 20 μg/ml FITC-conjugated antibodies against CD34 (BD), CD45 (BD), CD90 (BD), or CD105 (Abcam, Cambridge, UK). Non-specific FITC-conjugated mouse immunoglobulin G1κ (BD) was used as a negative control. The characteristics of the antibodies are listed in Table 2. The FITC-labeled cells were washed with SB and resuspended in 500 μl of SB for fluorescence-activated cell sorting (FACS) analysis. Cell fluorescence was evaluated as a strong shift in the mean fluorescence intensity (MFI) on flow cytometry using a FACSAria II instrument (BD). The data were analyzed using FACSDiva software (BD).
Table 1

List of PCR primers

Marker

Gene

Sequence (forward/reverse)

Ann. temp. (°C)

Fragment (bp)

Premature

OCT-4

5′-GTCGCCAGAAGGGCAAAC-3′

57.0

157

5′-CAGGGTGGTGAAGTGAGGG-3′

SOX-2

5′-CCCTGCAGTACAACTCCATGAC-3′

59.0

85

5′-GGTGCCCTGCTGCGAGTA-3′

KLF-4

5′-CGGCAAAACCTACACGAAGAGT-3′

59.0

119

5′-AGTTCATCTGAGCGGGCAAAT-3′

NANOG

5′-CTTATTCAGGACAGCCCTGATTCTTC-3′

59.0

613

5′-AAGACGGCCTCCAAATCACTG-3′

C-MYC

5′-GGATTCCGCCTCGTT-3′

55.1

184

5′-TCTCCAAGCATCACTCG-3′

Osteogenic

ALP

5′-ATGAGCTCAACCGGAACAA-3′

56.0

131

5′-GTGCCCATGGTCAATCCT-3′

OC

5′-TCAACCCCGACTGCGACGAG-3′

68.0

204

5′-TTGGAGCAGCTGGGATGATGG-3′

ON

5′-TCCGGATCTTTCCTTTGCTTTCTA-3′

57.5

187

5′-CCTTCACATCGTGGCAAGAGTTTG-3′

Chondrogenic

SOX-9

5′-CCGGTGCGCGTCAAC-3′

57.5

119

5′-TGCAGGTGCGGGTACTGAT-3′

AGG

5′-TTCCCTGAGGCCGAGAAC-3′

65.5

194

5′-GGGCGGTAATGGAACACAAC-3′

Adipogenic

PPAR-γ2

5′-GCGCCCTGGCAAAGCACT-3′

59.8

238

5′-TCCACGGAGCGAAACTGACAC-3′

AP2

5′-GGCCAAACCCAACCTGA-3′

59.8

167

5′-GGGCGCCTCCATCTAAG-3′

Housekeeping

GAPDH

5′-ACCACAGTCCATGCCATCAC-3′

60.0

450

5′-TCCACCACCCTGTTGCTGTA-3′

OCT-4 octamer-binding transcription factor 4, SOX-2 sex-determining region Y box 2; KLF-4 Krüppel-like factor 4, NANOG, homeobox protein NANOG, C-MYC, cellular myelocytomatosis oncogene, ALP alkaline phosphatase, OC osteocalcin, ON osteonectin, SOX-9 sex-determining region Y-box 9, AGG aggrecan, PPAR-γ2 peroxisome proliferator-activated receptor γ2, AP2 adipocyte fatty acid-binding protein 2, GAPDH glyceraldehyde-3-phosphate dehydrogenase.

Table 2

List of antibodies

Antibody

Company

Clone

Epitope

Dilution

CD34

BD

581

O-glycosylated transmembrane glycoprotein

1:5

CD45

BD

2D1

T200 family

1:2.5

CD90

BD

5E10

N-glycosylated GPI-linked membrane glycoprotein

1:10

CD105

Abcam

MEM229

Disulfide-linked glycoprotein homodimer

1:20

Isotype

BD

MOPC-21

(Not confirmed)

1:10

Tri-lineage analysis

To investigate osteogenic differentiation, the AT-MSCs were placed in six-well plates (6 Well Plate-N; Nest Biotech, Wuxi, China) in CCM at an initial density of 5,000 cells/cm2. After 24 h of incubation, the medium was replaced with osteogenic induction medium (Differentiation Basal Medium—Osteogenic; Lonza, Walkersville, MD), supplemented with 100 μM ascorbic acid, 10 mM β-glycerophosphate, and 1 μM dexamethasone, for 2 weeks. To investigate chondrogenic differentiation, AT-MSCs (5 × 105) were resuspended in a 15-ml culture tube (SuperClear centrifuge tubes; Labcon, Petaluma, CA) in 500 μl of chondrogenic induction medium (Differentiation Basal Medium—Chondrogenic, Lonza), supplemented with 4.5 g/l d-glucose, 350 μM l-proline, 100 nM dexamethasone, and 0.02 g/l transforming growth factor beta 3. Chondrogenic differentiation was induced in pellet cultures for 2 weeks. Adipogenic differentiation began when AT-MSCs reached a density of 5,000 cells/cm2 in six-well plates in CCM. Following a 24-h preincubation, the medium was replaced with Adipogenic Induction Medium (Lonza), supplemented with 4.5 g/l d-glucose, 100 μM indomethacin, 10 μg/ml insulin, 0.5 mM 3-isobutyl-1-methylxanthine, and 1 μM dexamethasone, for 3 days for induction of specific genes and molecules.

The PCR primers and conditions, and the expected sizes of the products are summarized in Table 1. The osteogenic marker genes were osteocalcin (OC), osteonectin (ON), and alkaline phosphatase (ALP). The chondrogenic marker genes were sex-determining region Y-box 9 (SOX-9) and aggrecan (AGG). The adipogenic marker genes were adipocyte fatty acid-binding protein 2 (AP2) and peroxisome proliferator-activated receptor γ2 (PPAR-γ2). The reaction products were electrophoresed in a 2% agarose gel (Agarose XP; Wako Pure Chemical Industries, Osaka, Japan), and the expressions of the specific genes were determined based on the expected sizes of the bands labeled with SYBR Green (Takara Bio).

Production of calcium apatite crystals in the osteogenic extracellular matrix was evaluated with alizarin red staining in the wells of culture plates. The chondrogenic cell pellets were fixed with 10% neutral buffered formalin (NBF), embedded in paraffin, and cut into 5-μm sections using a microsection instrument. The sections were stained with alcian blue to detect cartilage-specific proteoglycans. Adipocyte-specific intracellular lipids were stained with oil red O.

Preparation and implantation of 3D constructs of AT-MSCs

At least 4 × 107 AT-MSCs were used to produce each autologous construct. The cells were inoculated into eight 96-well plates (Sumitomo Bakelite, Tokyo, Japan) with 5 × 104 cells/well. After undisrupted incubation for 48 h, the cells formed spheroids with a diameter of about 700 μm in the bottom of the wells. About 760 spheroids were placed in a cylindrical mold and incubated in CCM until implantation (7 days). When the mold was carefully removed, a columnar construct of 4 mm in diameter and 6 mm in height appeared and was used for autologous implantation (Figure 1A). The general outline of this method of construction has already been reported [21,33].
Figure 1
Figure 1

Surgical procedure. A columnar construct (4 mm in diameter and 6 mm in height) for the implantation (A). A cylindrical osteochondral defect in each groove before implantation (B). The construct composed of about 760 spheroids of AT-MSCs was autografted into the osteochondral defect in the right hind limb (C). Nothing was implanted into the left limbs (control defects; B).

The implant surgery was performed under general anesthesia using oxygen and isoflurane inhalation following premedication with sedatives and analgesics. Both femoropatellar joints were incised from the outside, and the femoral trochlear groove was exposed. Using a surgical trephine with an outer diameter of 4 mm, the articular cartilage and subchondral bone were drilled to a depth of 6 mm at the center of the groove. After removing a column of cartilage and bone, a cylindrical osteochondral defect was created in each groove (Figure 1B). A columnar construct (4 mm in diameter and 6 mm in height) composed of spheroids of AT-MSCs was autografted into the osteochondral defect in the right hind limb (Figure 1C), while no graft was implanted into the defect in the left limb (control defect, Figure 1B).

Assessment of osteochondral defects

Postoperatively, the implants and osteochondral defects were followed up every month for 6 months in animal no. 1 and 12 months in animal no. 2 using computed tomography (CT) scans of both stifles. For assessment, longitudinal section images were obtained at the maximum diameter in lateral views of the cylindrical defect and the maximum diameters of the radiolucent area in the images were evaluated at 0.5-mm intervals between 0 and 9 mm.

Animal no. 1 was euthanized at 6 months after surgery, and animal no. 2 was euthanized at 12 months after surgery. The macroscopic findings were scored with the International Cartilage Repair Society (ICRS) gross grading scale (Table 3). Both distal femurs were fixed in 10% NBF for 1 week and then longitudinally sectioned parallel to the trochlear groove. The tissue was decalcified with formic acid for 1 week and embedded in paraffin. Serial sections (3-μm thickness) were placed on glass slides and evaluated by Masson’s trichrome staining, alcian blue staining, and immunohistochemistry using specific antibodies against collagen type II (Col-II; 1:100 dilution; Daiichi Fine Chemicals, Takaoka, Japan) and an Avidin-Biotin Enzyme Complex system (VECTASTAIN ABC Standard Kit; Vector Laboratories, Southfield, MI). The histopathologic findings were scored with the ICRS histological grading scale (Table 4).
Table 3

ICRS gross grading scale

Feature

Score

Animal no. 1

Animal no. 2

Control site

Implanted site

Control site

Implanted site

Coverage

>75% fill

4

2

3

4

4

50%–75% fill

3

25%–50% fill

2

<25% full

1

No fill

0

Neocartilage color

Normal

4

1

2

3

4

25% yellow/brown

3

50% yellow/brown

2

75% yellow/brown

1

100% yellow/brown

0

Defect margins

Invisible

4

1

2

3

3

25% circumference visible

3

50% circumference visible

2

75% circumference visible

1

Entire circumference visible

0

Surface

Smooth/level with normal

4

0

2

3

3

Smooth but raised

3

Irregular 25%–50%

2

Irregular 50%–75%

1

Irregular >75%

0

Average (0–4)

1.0

2.25

3.25

3.5

Table 4

ICRS histological grading scale

Feature

Score

Animal no. 1

Animal no. 2

Control site

Implanted site

Control site

Implanted site

Surface

Smooth/continuous

3

0

3

3

3

Discontinuities/irregularity

0

Matrix

Hyaline

3

0

1

1

2

Mixture; hyaline/fibrocartilage

2

Fibrocartilage

1

Fibrous tissue

0

Cell distribution

Columnar

3

0

0

0

2

Mixed/columnar clusters

2

Clusters

1

Individual cells/disorganized

0

Viability of cell population

Predominantly viable

3

3

3

3

3

Partially viable

1

<10% viable

0

Subchondral bone

Normal

3

1

2

0

2

Increased remodeling

2

Bone necrosis/granulation tissue

1

Detached/fracture/callus at base

0

Cartilage mineralization (calcified cartilage)

Normal

3

0

3

3

3

Abnormal/inappropriate location

0

Average (0–3)

0.67

2

1.67

2.5

Results

Genetic and molecular characteristics and tri-lineage potential of AT-MSCs

Porcine AT-MSCs adhering to the bottom of the culture dish were spindle-shaped and proliferated well (Figure 2A), reaching over 1 × 106 and 1 × 107 cells at passage 3 and passage 4, respectively. A strong shift in MFI on flow cytometry was detected with antibodies against CD90 and CD105 (Figure 3A, B), while no signals were detected with antibodies against CD34 and CD45 (Figure 3C, D). The genetic markers of OCT-4, SOX-2, KLF-4, C-MYC, and NANOG were all positive (Figure 4A). Following osteogenic induction, AT-MSCs aggregated and contracted to form colonies (Figure 2B), and expressions of specific marker genes, including ALP, OC, and ON, were detected (Figure 4B). These cells also showed appropriate characteristics of the stroma, including staining with alizarin red, indicating the presence of calcium apatite crystals (Figure 2B). Reverse transcription PCR (RT-PCR) of AT-MSCs placed in chondrogenic induction medium revealed the expressions of marker genes, including SOX-9 and AGG (Figure 4B). Histological observation of the cell pellets showed a hyaline cartilage-like structure that was positively stained with alcian blue (Figure 2C). Adipogenic induction of the AT-MSCs resulted in adipocyte-like flattened cells with small lipid vesicles that were positively stained with oil red O (Figure 2D). RT-PCR revealed significant increases in adipogenic marker gene expressions such as AP2 and PPAR-γ2 (Figure 4B).
Figure 2
Figure 2

Representative images of special staining and RT-PCR results of tri-lineage differentiation in AT-MSCs. AT-MSCs adhering to the bottom of the culture dish were spindle-shaped (A). Following 2 weeks of osteogenic induction, MSCs also showed characteristics of the stroma, including staining with alizarin red, indicating the presence of calcium apatite crystals (B). Observation of the cell pellets that were induced by chondrogenic induction medium for 2 weeks showed a cartilage-like structure that was positively stained with alcian blue (C). Adipogenic induction of the MSCs resulted in adipocyte-like flattened cells with small lipid vesicles that stained positively with oil red O (D).

Figure 3
Figure 3

Flow cytometry results of immunological markers in AT-MSCs. A strong shift in MFI was detected with antibodies against CD90 (A) and CD105 (B), whereas no signal reaction was detected with antibodies against CD34 (C) and CD45 (D).

Figure 4
Figure 4

RT-PCR results of gene expression in AT-MSCs. Premature gene expression in AT-MSCs (A) and specific marker gene expression in AT-MSCs induced by tri-lineage differentiation medium (B) were confirmed.

CT images

The reduction in the subchondral radiolucent area of the implanted site became more dramatic at 2 or 3 months after surgery compared with the control site in the both animals (Figure 5). CT images at 6 months after surgery for animal no. 1 are shown in Figure 5A. A radiopaque area emerged from the boundary between the bone and the implant and increased more steadily upward and inward for the implanted defect (the right femur) as time passed after surgery, compared with the control site. The radiolucent area of the implant diminished in a stepwise manner and then degraded to a diameter of 1 mm by 5 months after surgery. CT images at 12 months after surgery for animal no. 2 are shown in Figure 5B. A radiopaque area of the implant emerged in the same manner as in animal no. 1, gradually progressed, and then filled the entire osteochondral defect at 12 months after surgery. On the other hand, in the control site, a radiopaque area emerged in the shallow layer, but bone formation was not completed in the deep layer. The maximum diameter of the radiolucent area in the implanted site diminished in a stepwise manner and became 0 mm at 12 months after surgery. The control site remained at a diameter of 2.5 mm.
Figure 5
Figure 5

CT assessment of osteochondral defects. The upper image shows one cross section of the multiplanar reconstruction images 1, 3, and 6 months after the surgery in animal no. 1 (A). The lower image shows one cross section of the multiplanar reconstruction images 1, 6, 12 months after the surgery in animal no. 2 (B).

Macroscopic appearance and histopathology of the osteochondral defects

Macroscopic examination of animal no. 1 revealed that the surface of the implanted defect was covered with abundant cartilaginous white tissue (Figure 6A), while cartilaginous tissue was scarce and the surface was depressed in the control site (Figure 6B). Similarly, in animal no. 2, the surface was quite uniformly covered with abundant cartilaginous white tissues and the boundary to the surrounding normal cartilage was unclear in the implanted site (Figure 6C), compared with the findings at the control site (Figure 6D). The average macroscopic scores for the implanted site were higher than those for the control site in animal no. 1, while the differences between the scores for the implanted site and the control site were decreased in animal no. 2 (Table 3).
Figure 6
Figure 6

Macroscopic findings of the surface of the implanted and control sites. In animal no. 1, the surface of the implanted defect was covered with the abundant cartilaginous white tissues (A), whereas the cartilaginous tissue was scarce and the surface was depressed in the control site (B). In animal no. 2, the surface was more uniformly covered with abundant cartilaginous white tissues and the boundary to the surrounding normal cartilage was unclear in the implanted site (C), comparing to those of the control site (D).

Histopathological sections of animal no. 1 at 6 months after surgery showed that thickened fibrocartilage had developed over the subchondral bone that was regenerating in the implanted site (Figure 7A, B). The surface of the cartilage was smooth, and the boundary with the surrounding normal cartilage was obscure at the implanted site (Figure 7A). Meanwhile, the surface was collapsed and irregular at the control site (Figure 7C, D). The fibrocartilage showed more intense alcian blue staining and Col-II immunostaining at the implanted site (Figure 7E, F) compared with the control site (Figure 7G, H). In animal no. 2 at 12 months after surgery, partially thickened fibrocartilage was mounted on developed subchondral bone at the implanted site (Figure 7I, J). The surface of the cartilage was smooth, and the boundary with the surrounding normal cartilage was obscure, although small areas of endochondral ossification persisted at the center, and small amounts of AT had differentiated at the bottom part of the site (Figure 7I). Subchondral bone was symmetrically reconstructed in the defect and was covered by a mixed matrix of hyaline cartilage and fibrocartilage, in which clusters and columnar clusters of cells were observed (Figure 7J). In the control site, fibrocartilage had immediately covered the defect, but the subchondral ossification was poor (Figure 7K, L). The hyaline cartilage showed more intense and uniform alcian blue staining and Col-II immunostaining at the implanted site (Figure 7M, N) compared with the control site (Figure 7O, P). The averages of histologic scores for the implanted site were distinctly higher than those for the control site in both animals (Table 4).
Figure 7
Figure 7

Histopathology of osteochondral defects using Masson’s trichrome, alcian blue, and immunohistochemical staining of type II collagen. In animal no. 1, the articular surface was smooth and fibrocartilage developed on the subchondral bone at the implanted site (A, B, E, F), whereas the surface was irregular and fibrous tissue lay over the subchondral bone at the control site (C, D, G, H). At the implanted site in animal no. 2, the subchondral bone was symmetrically reconstructed and was covered by matrix including hyaline cartilage, which was suggested by the clusters (arrowhead) and columnar clusters (arrow) of cells (I, J, M, N). On the other hand, smooth and continuous surface was restored due to fibrocartilage formation, but subchondral bone was absent in the bottom half of the defect, at the control site in animal no. 2 (K, L, O, P). Black dotted lines indicate the areas of osteochondral defects immediately after the surgery. Masson’s trichrome staining sections (B, D, J, L) were enlarged from red dotted square in the images A, C, I, and K, respectively. The insert images in sections B, D, J, and L were enlarged from white dotted square in images B, D, J, and L, respectively. The bars in the insert images indicate 50 μm.

Discussion

Human AT-MSCs have been shown to be positive for CD90, which suppresses the cancerization of stem cells [34], and CD105, which is associated with cellular responses to blood vessel formation and TGF-β1 [34]. The porcine AT-derived and spindle-shaped cells adhering to the bottom of the culture dish in the present study were strongly positive for CD90 and CD105. CD34, which is involved in cell adhesion and is expressed in hematopoietic stem cells [34], and CD45, which activates T and B lymphocyte receptors in hematopoietic cells [34], were both negative in the porcine AT-derived cells. Because human hematopoietic cells, but not human MSCs, were positive for these molecules [35,36], the porcine AT-derived cells may not be contaminated with hematopoietic cells [37]. Genetic markers specific for human MSCs, such as SOX-2, OCT-4, NANOG [38], KLF-4, and C-MYC [39], were detected in the porcine cells by RT-PCR [40]. Moreover, the osteogenic, chondrogenic, and adipogenic potential of the cells was confirmed, and we therefore defined them as porcine AT-MSCs.

In accordance with a previously described procedure [21,33], we constructed scaffold-free 3D implants (diameter: 4 mm; height: 6 mm) composed of 760 spheroids each containing 5 × 104 autologous AT-MSCs. The cross-sectional CT images obtained at 6 and 12 months after implantation in animal no. 1 and animal no. 2, respectively, may mirror the histology because the localization, size, and shape of the radiolucent and radiopaque areas entirely corresponded with those of the fibrocartilage and regenerated bone. To further discriminate between cartilaginous and fibrous tissues in the radiolucent area, magnetic resonance imaging should be used.

The higher average macroscopic scores may suggest better improvement in superficial features at the implanted site, compared with the control site (Table 3). However, the differences in the average scores between the control and implanted sites were lower in animal no. 2 (euthanized at 12 months after surgery) than in animal no. 1 (euthanized at 6 months after surgery). All four features in the ICRS gross grading scale system were improved at the implanted site compared with the control defect site in animal no. 1, whereas a difference in neocartilage color only was seen between the two sites in animal no. 2. The results in animal no. 2 were not consistent with a previous study using rabbits, in which a more degraded macroscopic appearance of the control defect (diameter: 4.8 mm; depth: 5 mm) was observed at 12 months after implantation [21]. Based on the results, we speculate that the superficial features may improve spontaneously from 6 to 12 months after surgery for this size of osteochondral defect (diameter: 4 mm; depth: 6 mm) in MMPigs. To discriminate the superficial features caused by spontaneous repair from those caused by MSC-based regeneration in this size of defect, further evaluation of the pathology at 6 months after surgery will be appropriate in MMPigs. Other studies are needed to determine methods for repairing osteochondral defects with larger diameters and depths, which could never repair by themselves (as shown in the Additional files 1 and 2).

We also obtained higher average histologic scores at the implanted sites in both animals, which may indicate desirable osteochondral recovery compared with the control site (Table 4). As summarized in Table 5, regarding the histological features in animal no. 1, a smooth and continuous surface was restored by thickened fibrocartilage at the implanted site, whereas the surface was collapsed and irregular at the control site. Fibrocartilage formation and endochondral ossification during the process of MSC-based regeneration were present at the implanted site, compared with fibrous granulation matrix and inadequate bone formation in the control defect. On the other hand, in animal no. 2, a smooth and continuous articular surface was restored through cartilage formation at both sites, but subchondral bone formation was distinctly more satisfactory at the implanted site than at the control site, in which the trabecular pattern was completely absent (bone was detached) in the bottom half of the defect. Subchondral bone was covered by a mixed matrix of hyaline cartilage and fibrocartilage at the implanted site, while fibrocartilage had immediately covered the defect at the control site. These findings were similar to data reported previously reported in rabbits [21] and may suggest transformation of fibrocartilage into hyaline cartilage during the process of MSC-based osteocartilage regeneration. Because neither hyaline cartilage nor cell clusters were seen in the implanted defect site in animal no. 1, transformation of fibrocartilage into hyaline cartilage may begin between 6 and 12 months after implantation. However, more time may be required to regenerate pure, high-quality hyaline cartilage as well as complete subchondral regeneration in the implanted defect.
Table 5

Summary of histological features

 

Animal no. 1

Animal no. 2

Control site

Implanted site

Control site

Implanted site

Cartilage

Surface

Irregularity

Smooth

Smooth

Smooth

Matrix

Fibrous tissue

Fibrocartilage

Fibrocartilage

Mixture; hyaline/fibrocartilage (transformation)

Subchondral bone

Granulation tissue

Increased remodeling

Detached (in the bottom half of the defect)

Increased remodeling (endochondral ossification)

Consistent with a previous study on rabbits [21], we report here the successful outcome of osteochondral regeneration with scaffold-free AT-MSC constructs in MMPigs. Although further studies will be required, we conclude that implantation of a scaffold-free 3D construct of AT-MSCs into an osteochondral defect can regenerate the original structure of the bone and cartilage.

Conclusions

This pilot study suggests that implantation of a scaffold-free 3D construct of AT-MSCs into an osteochondral defect can induce regeneration of the original structure of the cartilage and subchondral bone over the course of 1 year.

Abbreviations

AGG: 

Aggrecan

ALP: 

Alkaline phosphatase

AP2: 

Adipocyte fatty acid-binding protein 2

AT: 

Adipose tissue

AT-MSCs: 

Adipose tissue-derived mesenchymal stem cells

BM: 

Bone marrow

BM-MSCs: 

Bone marrow-derived mesenchymal stem cells

CCM: 

Complete culture medium

C-MYC: 

Cellular myelocytomatosis oncogene

Col-II: 

Collagen type II

CT: 

Computed tomography

DMEM: 

Dulbecco’s modified Eagle’s medium

EDTA: 

Ethylenediaminetetraacetate

FACS: 

Fluorescence-activated cell sorting

FBS: 

Fetal bovine serum

KLF-4: 

Krüppel-like factor 4

MFI: 

Mean fluorescence intensity

MMPigs: 

Microminipigs

MSCs: 

Mesenchymal stem cells

NANOG: 

Homeobox protein NANOG

NBF: 

Neutral buffered formalin

TGF-β3: 

Transforming growth factor beta 3

OA: 

Osteoarthritis

OC: 

Osteocalcin

OCT-4: 

Octamer-binding transcription factor 4

ON: 

Osteonectin

PBS: 

Phosphate-buffered saline

PPAR-γ2: 

Peroxisome proliferator-activated receptor γ2

SB: 

Staining buffer

SOX-2: 

Sex-determining region Y box 2

SOX-9: 

Sex-determining region Y-box 9

Declarations

Acknowledgements

This study was supported by Japan Society for the Promotion of Science (grant no. 23380185 to KM). The study sponsor had no involvement in this study design, collection, analysis, or interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.

Authors’ Affiliations

(1)
Veterinary Surgery, Department of Veterinary Clinical Science, Joint Faculty of Veterinary Medicine, Kagoshima University, 21-24 Korimoto 1-chome, Kagoshima 890-0065, Japan
(2)
Veterinary Teaching Hospital, Joint Faculty of Veterinary Medicine, Kagoshima University, 21-24 Korimoto 1-chome, Kagoshima 890-0065, Japan
(3)
Cyfuse Biomedical K.K., 1-1 Maidashi 3-chome, Higashi-ku Fukuoka, 812-8582, Japan
(4)
Veterinary Pathology, Department of Pathological and Preventive Sciences, Joint Faculty of Veterinary Medicine, Kagoshima University, 21-24 Korimoto 1-chome, Kagoshima 890-0065, Japan
(5)
Department of Advanced Technology Fusion, Graduate School of Science and Engineering, Saga University, Honjyo 1-chome, Honjyo-cho Saga, 840-8502, Japan

References

  1. Muraki S, Oka H, Akune T, Mabuchi A, En-Yo Y, Yoshida M, et al. Prevalence of radiographic knee osteoarthritis and its association with knee pain in the elderly of Japanese population-based cohorts: the ROAD study. Osteoarthr Cartil. 2009;17:1137–43.View ArticlePubMedGoogle Scholar
  2. Gelber AC, Hochberg MC, Mead LA, Wang NY, Wigley FM, Klag MJ. Joint injury in young adults and risk for subsequent knee and hip osteoarthritis. Ann Intern Med. 2000;133:321–8.View ArticlePubMedGoogle Scholar
  3. Fernandes JC, Martel-Pelletier J, Pelletier JP. The role of cytokines in osteoarthritis pathophysiology. Biorheology. 2002;39:237–46.PubMedGoogle Scholar
  4. Ding C, Cicuttini F, Scott F, Cooley H, Boon C, Jones G. Natural history of knee cartilage defects and factors affecting change. Arch Intern Med. 2006;166:651–8.View ArticlePubMedGoogle Scholar
  5. Muraki S, Akune T, Oka H, Mabuchi A, En-Yo Y, Yoshida M, et al. Association of occupational activity with radiographic knee osteoarthritis and lumbar spondylosis in elderly patients of population-based cohorts: a large-scale population-based study. Arthritis Rheum. 2009;61:779–86.View ArticlePubMedGoogle Scholar
  6. Mankin HJ. The response of articular cartilage to mechanical injury. J Bone Joint Surg Am. 1982;64:460–6.PubMedGoogle Scholar
  7. Lane JG, Massie JB, Ball ST. Follow-up of osteochondral plug transfers in a goat model: a 6-month study. Am J Sports Med. 2004;32:1440–50.View ArticlePubMedGoogle Scholar
  8. Szerb I, Hangody L, Duska Z, Kaposi NP. Mosaicplasty: long-term follow-up. Bull Hosp Jt Dis. 2005;63:54–62.PubMedGoogle Scholar
  9. Bentley G, Biant LC, Carrington RW, Akmal M, Goldberg A, Williams AM, et al. A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. J Bone Joint Surg (Br). 2003;85:223–30.View ArticleGoogle Scholar
  10. Fujisato T, Sajiki T, Liu Q, Ikada Y. Effect of basic fibroblast growth factor on cartilage regeneration in chondrocyte-seeded collagen sponge scaffold. Biomaterials. 1996;17:155–62.View ArticlePubMedGoogle Scholar
  11. Funayama A, Niki Y, Matsumoto H, Maeno S, Yatabe T, Morioka H, et al. Repair of full-thickness articular cartilage defects using injectable type II collagen gel embedded with cultured chondrocytes in a rabbit model. J Orthop Sci. 2008;13:225–32.View ArticlePubMedGoogle Scholar
  12. Diaz-Romero J, Gaillard JP, Grogan SP, Nesic D, Trub T, Mainil-Varlet P. Immunophenotypic analysis of human articular chondrocytes: changes in surface markers associated with cell expansion in monolayer culture. J Cell Physiol. 2005;202:731–42.View ArticlePubMedGoogle Scholar
  13. Tatebe M, Nakamura R, Kagami H, Okada K, Ueda M. Differentiation of transplanted mesenchymal stem cells in a large osteochondral defect in rabbit. Cytotherapy. 2005;7:520–30.View ArticlePubMedGoogle Scholar
  14. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–7.View ArticlePubMedGoogle Scholar
  15. Zuk PA, Zhu M, Ashjian P, De-Ugarte DA, Huang JI, Mizuno H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Bio Cell. 2002;13:4279–95.View ArticleGoogle Scholar
  16. Gurevitch O, Slavin S, Resnick I, Khitrin S, Feldman A. Mesenchymal progenitor cells in red and yellow bone marrow. Folia Biol. 2009;55:27–34.Google Scholar
  17. Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev. 2008;129:163–73.View ArticlePubMedGoogle Scholar
  18. Asumda FZ, Chase PB. Age-related changes in rat bone-marrow mesenchymal stem cell plasticity. BMC Cell Biol. 2011;12:44.View ArticlePubMed CentralPubMedGoogle Scholar
  19. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211–28.View ArticlePubMedGoogle Scholar
  20. Nakamura T, Sekiya I, Muneta T, Hatsushika D, Horie M, Tsuji K, et al. Arthroscopic, histological and MRI analyses of cartilage repair after a minimally invasive method of transplantation of allogeneic synovial mesenchymal stromal cells into cartilage defects in pigs. Cytotherapy. 2012;14:327–38.View ArticlePubMed CentralPubMedGoogle Scholar
  21. Ishihara K, Nakayama K, Akieda S, Matsuda S, Iwamoto Y. Simultaneous regeneration of full-thickness cartilage and subchondral bone defects in vivo using a three-dimensional scaffold-free autologous construct derived from high-density bone marrow-derived mesenchymal stem cells. J Orthop Surg Res. 2014;9:98.View ArticlePubMed CentralPubMedGoogle Scholar
  22. Lu Z, Doulabi BZ, Huang C, Bank RA, Helder MN. Collagen type II enhances chondrogenesis in adipose tissue-derived stem cells by affecting cell shape. Tissue Eng Part A. 2010;16:81–90.View ArticlePubMedGoogle Scholar
  23. Yoon IS, Chung CW, Sung JH, Cho HJ, Kim JS, Shim WS, et al. Proliferation and chondrogenic differentiation of human adipose-derived mesenchymal stem cells in porous hyaluronic acid scaffold. J Biosci Bioeng. 2011;112:402–8.View ArticlePubMedGoogle Scholar
  24. Arrigoni E, De-Girolamo L, Di-Giancamillo A, Stanco D, Dellavia C, Carnelli D, et al. Adipose-derived stem cells and rabbit bone regeneration: histomorphometric, immunohistochemical and mechanical characterization. J Orthop Sci. 2013;18:331–9.View ArticlePubMedGoogle Scholar
  25. Park CW, Rhee YS, Park SH, Danh SD, Ahn SH, Chi SC, et al. In vitro/in vivo evaluation of NCDS-micro-fabricated biodegradable implant. Arch Pharm Res. 2010;33:427–32.View ArticlePubMedGoogle Scholar
  26. Koga H, Shimaya M, Muneta T, Nimura A, Morito T, Hayashi M, et al. Local adherent technique for transplanting mesenchymal stem cells as a potential treatment of cartilage defect. Arthritis Res Ther. 2008;10:R84.View ArticlePubMed CentralPubMedGoogle Scholar
  27. Dashtdar H, Rothan HA, Tay T, Ahmad RE, Ali R, Tay LX, et al. A preliminary study comparing the use of allogenic chondrogenic pre-differentiated and undifferentiated mesenchymal stem cells for the repair of full thickness articular cartilage defects in rabbits. J Orthop Res. 2011;29:1336–42.View ArticlePubMedGoogle Scholar
  28. Lee JI, Sato M, Kim HW, Mochida J. Transplantation of scaffold-free spheroids composed of synovium-derived cells and chondrocytes for the treatment of cartilage defects of the knee. Eur Cell Mater. 2011;22:275–90.PubMedGoogle Scholar
  29. Yoshioka T, Mishima H, Kaul Z, Ohyabu Y, Sakai S, Ochiai N, et al. Fate of bone marrow mesenchymal stem cells following the allogeneic transplantation of cartilaginous aggregates into osteochondral defects of rabbits. J Tissue Eng Regen Med. 2011;5:437–43.View ArticlePubMedGoogle Scholar
  30. Suzuki S, Muneta T, Tsuji K, Ichinose S, Makino H, Umezawa A, et al. Properties and usefulness of aggregates of synovial mesenchymal stem cells as a source for cartilage regeneration. Arthritis Res Ther. 2012;14:R136.View ArticlePubMed CentralPubMedGoogle Scholar
  31. Kawaguchi H, Miyoshi N, Miura N, Fujiki M, Horiuchi M, Izumi Y, et al. Microminipig, a non-rodent experimental animal optimized for life science research: novel atherosclerosis model induced by high fat and cholesterol diet. J Pharmacol Sci. 2011;115:115–21.View ArticlePubMedGoogle Scholar
  32. Takeishi K, Horiuchi M, Kawaguchi H, Deguchi Y, Izumi H, Arimura E, et al. Acupuncture improves sleep conditions of minipigs representing diurnal animals through an anatomically similar point to the acupoint (GV20) effective for humans. Evid Based Complement Alternat Med. 2012;2012:472982.View ArticlePubMed CentralPubMedGoogle Scholar
  33. Nakayama K. In vitro biofabrication of tissues and organs. In: Forgacs G, Sun W, editors. Biofabrication: micro- and nano-fabrication, printing, patterning and assemblies. Oxford: William Andrew; 2013. p. 1–21.View ArticleGoogle Scholar
  34. Zola H, Swart B, Nicholson I, Voss E. Leukocyte and stromal cell molecules: the CD markers. Hoboken: John Wiley & Sons Inc; 2007.Google Scholar
  35. Chen J, Lu Z, Cheng D, Peng S, Wang H. Isolation and characterization of porcine amniotic fluid-derived multipotent stem cells. PLoS One. 2011;6:e19964.View ArticlePubMed CentralPubMedGoogle Scholar
  36. Guo KT, SchAfer R, Paul A, Gerber A, Ziemer G, Wendel HP. A new technique for the isolation and surface immobilization of mesenchymal stem cells from whole bone marrow using high-specific DNA aptamers. Stem Cells. 2006;10:2220–31.View ArticleGoogle Scholar
  37. Casado JG, Gomez-Mauricio G, Alvarez V, Mijares J, Tarazona R, Bernad A, et al. Comparative phenotypic and molecular characterization of porcine mesenchymal stem cells from different sources for translational studies in a large animal model. Vet Immunol Immunopathol. 2012;147:104–12.View ArticlePubMedGoogle Scholar
  38. Riekstina U, Cakstina I, Parfejevs V, Hoogduijn M, Jankovskis G, Muiznieks I, et al. Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis. Stem Cell Rev. 2009;5:378–86.View ArticlePubMedGoogle Scholar
  39. Windmolders S, De-Boeck A, Koninckx R, Daniëls A, De-Wever O, Bracke M, et al. Mesenchymal stem cell secreted platelet derived growth factor exerts a pro-migratory effect on resident cardiac atrial appendage stem cells. J Mol Cell Cardiol. 2014;66:177–88.View ArticlePubMedGoogle Scholar
  40. Tang L, Yin Y, Zhou H, Song G, Fan A, Tang B, et al. Proliferative capacity and pluripotent characteristics of porcine adult stem cells derived from adipose tissue and bone marrow. Cell Reprogram. 2012;14:342–52.PubMed CentralPubMedGoogle Scholar

Copyright

© Murata et al.; licensee BioMed Central. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement

Journal of Orthopaedic Surgery and Research

ISSN: 1749-799X